European Commission approves Janssen-Cilag International Rybrevant, Lazcluze combo for first-line treatment of lung cancer Ruchika Sharma31 Dec 2024 11:30 AM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the European Commission (EC) has approved a Type II...
Pfizer ceases development of Hemophilia A gene therapy Giroctocogene Fitelparvovec Ruchika Sharma31 Dec 2024 10:00 AM ISTRichmond: Sangamo Therapeutics, Inc., a genomic medicine company, has announced it will regain development and commercialization rights to...
CDSCO Panel Approves Eli Lilly's Protocol Amendment Proposal for Mirikizumab study Dr. Divya Colin30 Dec 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Eli...
CDSCO Panel rejects Zydus Healthcare's proposal to waive Phase III CT of Diphenhydramine, Phenylephrine FDC Dr. Divya Colin30 Dec 2024 5:45 PM ISTNew Delhi: Denying the proposal for a phase III clinical trial (CT) waiver, the Subject Expert Committee (SEC) functional under the Central Drug...
Delhi: Woman arrested for illegally selling Mephentermine injections to gym goers Ruchika Sharma30 Dec 2024 3:39 PM ISTNew Delhi: A woman was arrested for allegedly selling psychotropic injections of mephentermine to gym-goers illegally without a prescription or...
Zydus Wellness subsidiary receives GST demand of Rs 56.33 crore Ruchika Sharma30 Dec 2024 1:05 PM ISTAhmedabad: Zydus Wellness Products Limited, a wholly owned subsidiary of Zydus Wellness, has received a GST demand of Rs 56.33 crores along...
Reliance buys Karkinos Healthcare for Rs 375 crore Ruchika Sharma30 Dec 2024 12:20 PM ISTMumbai: Reliance Industries has acquired Karkinos Healthcare through its wholly-owned subsidiary Reliance Strategic Business Ventures...
CDSCO Panel Approves Eli Lilly's Protocol Amendment Proposal for Antidiabetic Drug Retatrutide study Dr. Divya Colin29 Dec 2024 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Eli...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal To Study antihypertensive drug Baxdrostat Dr. Divya Colin29 Dec 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the pharmaceutical...
Daiichi Sankyo Datroway approved in Japan for breast cancer Ruchika Sharma29 Dec 2024 12:00 PM ISTTokyo: Daiichi Sankyo's DATROWAY (datopotamab deruxtecan) has been approved in Japan for the treatment of adult patients with hormone receptor...
BioNTech enters settlement with US National Institutes of Health, University of Pennsylvania Ruchika Sharma29 Dec 2024 10:00 AM ISTBengaluru: German biotechnology company BioNTech has reached two separate settlement agreements with the U.S. National Institutes of Health (NIH)...
IQVIA Gets CDSCO Panel Nod To conduct Phase III clinical Study of Lumateperone Dr. Divya Colin28 Dec 2024 6:30 PM ISTNew Delhi: IQVIA has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to...
